Felip E - Search Results

1

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study.

Felip E, Rosell R, Domine M, Santomé L, Garrido P, Font A, Carrato A, Terrasa J, Vadell C, Mañe JM, Baselga J; Spanish Lung Cancer Group. Felip E, et al. Ann Oncol. 2003 Oct;14(10):1549-54. doi: 10.1093/annonc/mdg405. Ann Oncol. 2003. PMID: 14504057 Free article. Clinical Trial.

2

Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.

Del Campo JM, Felip E, Rubio D, Vidal R, Bermejo B, Colomer R, Zanon V. Del Campo JM, et al. Among authors: felip e. Gynecol Oncol. 1994 Apr;53(1):27-32. doi: 10.1006/gyno.1994.1082. Gynecol Oncol. 1994. PMID: 8175018 Clinical Trial.

3

Preoperative simultaneous chemoradiotherapy in locally advanced cancer of the oral cavity and oropharynx.

del Campo JM, Felip E, Giralt J, Raspall G, Bescos S, Casado S, Maldonado X. del Campo JM, et al. Among authors: felip e. Am J Clin Oncol. 1997 Feb;20(1):97-100. doi: 10.1097/00000421-199702000-00022. Am J Clin Oncol. 1997. PMID: 9020299 Clinical Trial.

4

Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.

Felip E, Del Campo JM, Bodi R, Vera R, Casado S, Rubio D. Felip E, et al. Am J Clin Oncol. 1997 Aug;20(4):404-6. doi: 10.1097/00000421-199708000-00017. Am J Clin Oncol. 1997. PMID: 9256899 Clinical Trial.

5

A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.

Rosell R, Felip E, Massuti B, González-Larriba JL, Benito D, López-Cabrerizo MP, Salamanca O, Camps C, Puerto-Pica J. Rosell R, et al. Among authors: felip e. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-56-S12-60. Semin Oncol. 1997. PMID: 9331123 Clinical Trial.

6

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.

Felip E, Massuti B, Camps C, Benito D, Isla D, González-Larriba JL, López-Cabrerizo MP, Salamanca O, Puerto-Pica J, Moyano A, Baselga J, Rosell R. Felip E, et al. Clin Cancer Res. 1998 Nov;4(11):2723-8. Clin Cancer Res. 1998. PMID: 9829735 Clinical Trial.

7

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A, Abad A. Monzó M, et al. Among authors: felip e. J Clin Oncol. 1999 Jul;17(7):2100-4. doi: 10.1200/JCO.1999.17.7.2100. J Clin Oncol. 1999. PMID: 10561264

8

Role of multimodality treatment for lung cancer.

Rosell R, Felip E. Rosell R, et al. Among authors: felip e. Semin Surg Oncol. 2000 Mar;18(2):143-51. doi: 10.1002/(sici)1098-2388(200003)18:2<143::aid-ssu8>3.0.co;2-i. Semin Surg Oncol. 2000. PMID: 10657916 Review.

9

Is the evidence in favour of neoadjuvant chemotherapy in stage IIIA (N2) non-small cell lung cancer solid enough?

Felip E, Rosell R. Felip E, et al. Monaldi Arch Chest Dis. 2000 Aug;55(4):305-10. Monaldi Arch Chest Dis. 2000. PMID: 11057084 Review.

10

Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer.

Isla D, Rosell R, Sánchez JJ, Carrato A, Felip E, Camps C, Artal A, González-Larriba JL, Azagra P, Alberola V, Martin C, Massutí B; Spanish Lung Cancer Group. Isla D, et al. Among authors: felip e. J Clin Oncol. 2001 Feb 15;19(4):1071-7. doi: 10.1200/JCO.2001.19.4.1071. J Clin Oncol. 2001. PMID: 11181671 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

579 results

Search Page

Filters